NSECertificate under SEBI (Depositories and Participants) Regulations, 20186 Oct 2026 · 6 Oct 2026, 03:24 pm

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Alembic Pharmaceuticals Limited · APLLTD

✦ AI Summary

Alembic Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half year ended 30th September, 2026.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Alembic Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Attachments (1)

📄

APLLTD_06102026152350_Certificate-74_5_-BSE-NSE-signed.pdf

pdf

Download →
View document text
Date: 6th October, 2026 To, To, The Manager, The Manager, BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, ‘Exchange Plaza’, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 BSE Scrip Code: 533573 NSE Symbol: APLLTD Dear Sir/Madam, Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half year ended 30th September, 2026 With reference to the captioned matter, please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half year ended 30th September, 2026 received from M/s. MUFG lntime India Private Limited (Formerly known as M/s. Link lntime India Private Limited), Registrar and Share Transfer Agent of our Company. We request you to kindly take the same on record. Thanking you, Yours faithfully, For Alembic Pharmaceuticals Limited Chirag K. Shukla Company Secretary Encl.: A/a. ALEMBIC PHARMACEUTICALS LIMITED REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229 Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123 MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) CIN: U67190MH1999PTC118368 Registered Address: C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400083. Tel: +91 22 4918 6000 www.in.mpms.mufg.com To, Date : 03-10-2026 The Compliance Officer/ Company Secretary ALEMBIC PHARMACEUTICALS LIMITED ALEMBIC ROAD, VADODARA PINCODE : 390003 Sub : Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. Dear Sir/Madam, In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for dematerialisation during the quarter ended 30th September 2026, were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed. We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the security certificates received were mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request you to kindly take note of the above in your records. Thanking you, Yours faithfully, For MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) Ashok Shetty Sr. Vice President-Corporate Registry MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services